Wexford Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,000
| Closed | -$1.03M | – | 167 |
|
|
2024
Q2 | $1.03M | Hold |
6,000
| – | – | 0.26% | 63 |
|
|
2024
Q1 | $1.09M | Buy |
+6,000
| New | +$1.09M | 0.22% | 81 |
|
|
2023
Q3 | – | Sell |
-3,619
| Closed | -$488K | – | 181 |
|
|
2023
Q2 | $488K | Buy |
+3,619
| New | +$488K | 0.1% | 109 |
|
|
2021
Q1 | – | Sell |
-29,424
| Closed | -$3.15M | – | 191 |
|
|
2020
Q4 | $3.15M | Sell |
29,424
-78,265
| -73% | -$8.39M | 0.49% | 55 |
|
|
2020
Q3 | $9.43M | Buy |
107,689
+18,660
| +21% | +$1.63M | 2.52% | 8 |
|
|
2020
Q2 | $8.74M | Buy |
+89,029
| New | +$8.74M | 2.2% | 13 |
|
|
2016
Q3 | – | Sell |
-32,958
| Closed | -$2.04M | – | 158 |
|
|
2016
Q2 | $2.04M | Buy |
32,958
+19,740
| +149% | +$1.22M | 0.35% | 61 |
|
|
2016
Q1 | $755K | Sell |
13,218
-41,265
| -76% | -$2.36M | 0.15% | 81 |
|
|
2015
Q4 | $3.23M | Sell |
54,483
-54,407
| -50% | -$3.22M | 0.76% | 35 |
|
|
2015
Q3 | $5.93M | Buy |
+108,890
| New | +$5.93M | 1.15% | 36 |
|
|
2014
Q4 | – | Sell |
-25,000
| Closed | -$1.44M | – | 51 |
|
|
2014
Q3 | $1.44M | Buy |
+25,000
| New | +$1.44M | 0.13% | 71 |
|